High-risk HPV (Any Strain)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which High-risk HPV (Any Strain) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07572396

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo…

The goal of this clinical trial is to learn if an investigational vaginal suppository therapy works to treat low-grade cervical lesions (ASC-US and LSIL) associ…

Hong Kong45 participantsStarted 2026-04-30

Treatment: EGCG and Quinine Sulfate Vaginal Suppository, Placebo

All recent trials (3 shown)

Not Yet RecruitingPhase 2

NCT07303751

Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV

This is a randomized, open-label trial, to assess whether a single dose of HPV nonavalent vaccine, administered to HIV uninfected, unvaccinated women with high…

Sierra Leone80 participantsStarted 2026-02-01

Treatment: Nonavalent HPV vaccine (9vHPV)

CompletedPhase 1

NCT02354534

Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)

This phase I research protocol is designed to assess immunogenicity and clinical endpoints in patients with human papillomavirus (HPV) 16 cervical intraepitheli…

United States30 participantsStarted 2015-02

Treatment: Artesunate Suppositories